计算溶液所需的质量、体积或浓度。
,适用于对基线干扰要求严格的色谱和分析工作流程。
-80℃储存。特低温运输 。请查阅批次 COA 获取详细规格。
SDS、COA、产品数据表及规格说明书均可下载。可通过批号查询获取批次 COA。
在色谱分析、有机合成和交叉偶联反应领域已被 0 篇同行评审文献引用。
Ranolazine Dihydrochloride is a novel metabolic modulator and membrane stabilizer that is an antianginal and antiischaemic agent. This compound shifts myocardial energy metabolism away from free fatty acids and toward glucose as the substrate for production of adenosine triphosphate. Ranolazine Dihydrochloride is an activator of PDK.A novel metabolic modulator.
Information
Ranolazine 2HCl Ranolazine 2HCl (RS-43285) is a calcium uptake inhibitor via the sodium/calcium channal , used to treat chronic angina.
In vitro
Ranolazine\xa0selectively inhibits\xa0late\xa0I(Na), reduces [Na(+)](i)-dependent calcium overload and attenuates the abnormalities of ventricular repolarisation and contractility that are associated with ischaemia/reperfusion and heart failure in myocardial cells. Ranolazine\xa0significantly and reversibly shortens the action potential duration (APD) of\xa0myocytes\xa0stimulated at either 0.5 Hz or 0.25 Hz in a concentration-dependent manner in left ventricular myocytes of dogs.\xa0Ranolazine\xa0at 5 and 10 mM reversibly shortens the duration of twitch\xa0contractions\xa0(TC) and abolished the after\xa0contraction. Ranolazine\xa0is found to bind more tightly to the inactivated state than the resting state of the\xa0sodium\xa0channel underlying I(NaL).
In vivo
Ranolazine\xa0(10 mM) significantly increases\xa0glucose\xa0oxidation\xa01.5-fold to 3-fold under conditions in which the contribution of\xa0glucoseto overall ATP production is low (low Ca, high FA, with insulin), high (high Ca, low Fa, with pacing), or intermediate in working\xa0hearts. Ranolazine\xa0similarly increases glucose\xa0oxidation in\xa0normoxic\xa0Langendorff\xa0hearts\xa0(high Ca, low FA; 15 mL/min). Ranolazine\xa0also significantly increases it during flow reduction to 7 mL/min, 3 mL/min, and 0.5 mL/min. Ranolazine\xa0significantly improves functional outcome, which is associated with significant increases in\xa0glucoseoxidation, a reversal of the increased FA\xa0oxidation\xa0seen in control reperfusions (versus preischemic), and a smaller but significant increase in glycolysis in\xa0reperfuse dischemic\xa0working\xa0hearts.
Cell Data
cell lines:
Concentrations:
Incubation Time:
Powder Purity:≥99%
H315: 引起皮肤刺激
H319: 引起严重眼睛刺激
H335: 可能引起呼吸道刺激
H302: 吞食有害
P261: 避免吸入灰尘/烟雾/气体/雾/蒸汽/喷雾
P305+P351+P338: 如进入眼睛:用水小心冲洗几分钟。如戴隐形眼镜并可方便地取出,取出隐形眼镜。继续冲洗。
P280: 戴防护手套/穿防护服/戴防护眼罩/戴防护面具。
P302+P352: 如皮肤沾染:用水充分清洗。
P321: 特殊处理(请参阅此标签上的...)。
P405: 密闭存放
P501: 将内容物/容器处理到。。。
P264: 处理后要彻底洗手。
P271: 仅在室外或通风良好的地方使用。
P270: 使用本产品时,请勿进食、饮水或吸烟。
P304+P340: 如误吸入:将人转移到空气新鲜处,保持呼吸舒适体位。
P403+P233: 存放在通风良好的地方。保持容器密闭。
P362+P364: 脱掉沾污的衣服,清洗后方可重新使用。
P330: 漱口
P264+P265: 处理后彻底洗手[和…]。不要触摸眼睛。
P301+P317: 如果被吞咽:请寻求医疗帮助。
P337+P317: 如果眼睛刺激持续:寻求医疗帮助。
P332+P317: 如果出现皮肤刺激:请寻求医疗帮助。
P319: 如果你感到不适,请寻求医疗帮助。